Copyright
©The Author(s) 2020.
World J Gastroenterol. Sep 7, 2020; 26(33): 4945-4959
Published online Sep 7, 2020. doi: 10.3748/wjg.v26.i33.4945
Published online Sep 7, 2020. doi: 10.3748/wjg.v26.i33.4945
Figure 4 Histological staining showed colitis induced dysfunction.
A: Dextran sulfate sodium group showed significant colonic mucosal damages, crypt depletion, infiltration of inflammatory cells into the mucosa and submucosa, loss of epithelial barrier. Resveratrol treatment group and 5-aminosalicylic acid could alleviate colitis-induced intestinal mucosal barrier dysfunction; and B: The histological score of resveratrol treatment group was lower than the dextran sulfate sodium group. aP < 0.05. DSS: Dextran sulfate sodium; 5-ASA: 5-aminosalicylic acid; RES: Resveratrol.
- Citation: Pan HH, Zhou XX, Ma YY, Pan WS, Zhao F, Yu MS, Liu JQ. Resveratrol alleviates intestinal mucosal barrier dysfunction in dextran sulfate sodium-induced colitis mice by enhancing autophagy. World J Gastroenterol 2020; 26(33): 4945-4959
- URL: https://www.wjgnet.com/1007-9327/full/v26/i33/4945.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i33.4945